Parkinson’s Disease

Kevin Bonavia Excerpts

Monday 17th November 2025 Westminster Hall

[Paul Davies]

Again, I absolutely agree. I know from talking to one of my constituents, Liz Ryan, that that physical support and that ability to do something, get involved in activities and have help are of immense value. We absolutely have to have a holistic view of this issue; it is not a simple case of just medication or taking people into a clinical environment. We have to look at what we can do within communities, as was mentioned earlier, and at how we can support people with their lives and ensure that they live their lives to their full potential.

Some of the innovative medicines can certainly be life-changing for those with severe symptoms, but staffing and funding constraints mean that many hospitals cannot offer those solutions. Access to new treatments must not be a postcode lottery.

I want to take a moment to share some encouraging news from my constituency. We currently have a neurology registrar based in Leeds who is spending a significant amount of time seeing Parkinson’s patients in Huddersfield. He works alongside a dedicated doctor who also travels from Leeds to support patients at Huddersfield Royal infirmary. Just last month, they met the operations director at Huddersfield Royal infirmary, who shared some good news: in December, the trust will be advertising for a consultant neurologist with a special interest in Parkinson’s.

The role will be based in Leeds but will include a significant commitment to patients in Huddersfield. That is a direct result of our local campaign, and in particular the tireless work of our local Parkinson’s community group, led by Liz Ryan MBE and Dr Chris Ryan. It shows what can be achieved when patients, families, clinicians and elected representatives work together.

[Kevin Bonavia (Stevenage) (Lab)]

I thank my hon. Friend for leading today’s debate, and the Movers and Shakers for promoting both the debate and the Parky charter. My hon. Friend talks about working together. One of the issues I have heard from constituents in Stevenage is misdiagnosis at the outset, where GPs have not identified the condition or referred patients to the right pathway. Does my hon. Friend agree that it is not just about funding, but about training as well?

[Paul Davies]

Certainly. In the discussion I referred to earlier with the neurologist specialist, we talked quite a bit about that as well: the difficulty with diagnosis and the similarities between Parkinson’s and other neurological illnesses and issues. My hon. Friend is right: there is absolutely a need to ensure that GPs at least recognise some triggers or areas so that patients can get specialist support. Without early diagnosis, many people suffer unnecessarily for many years, and the support that could help to alleviate some of these issues is not getting to them.